$ABEO 8-K SEC Filings

Filed On	Filing
15 Sep 2026	8-K: Regulation FD Disclosure Abeona Therapeutics Inc. is furnishing in this Current Report on Form 8-K an updated investor presentation (the “Investor Presentation”) that it expects to use, either in whole or in part, on September 15, 2026 at the H.C. Wainwright 28t...
13 Aug 2026	8-K: Results of Operations and Financial Condition
12 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
12 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation
10 Jun 2026	8-K: Regulation FD Disclosure
04 Jun 2026	8-K: Other Events
13 May 2026	8-K: Results of Operations and Financial Condition
07 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
20 Mar 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
17 Mar 2026	8-K: Results of Operations and Financial Condition
09 Mar 2026	8-K: Other Events
12 Nov 2025	8-K: Results of Operations and Financial Condition
14 Aug 2025	8-K: Results of Operations and Financial Condition
18 Jul 2025	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
02 Jul 2025	8-K: Completion of Acquisition or Disposition of Assets; Results of Operations and Financial Condition +1 more
19 May 2025	8-K: Submission of Matters to a Vote of Security Holders
15 May 2025	8-K: Results of Operations and Financial Condition
12 May 2025	8-K: Entry into a Material Definitive Agreement; Other Events
29 Apr 2025	8-K: Regulation FD Disclosure
29 Apr 2025	8-K: Other Events

Comments